{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-025770","form_type":"8-K","ticker":"ETST","cik":"0001538495","company_name":"Earth Science Tech, Inc.","filed_at":"2023-07-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.246613+00:00","generated_at":"2026-06-12T23:01:08.741859+00:00","sec_items":["7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Earth Science Tech reports record Q1: revenue $219,934 vs $0 YoY; cash up 352%","bullets":["Revenue $219,934 vs $0 in Q1 2022; gross profit $148,769 vs $0.","Cash $91,989 (+352% YoY); total assets $2,752,719 (+759% YoY).","Liabilities down 44.59% to $1,263,660; stockholders' equity up 176%.","Subsidiary RxCompound received sterile lab approval; launched ViagraMia.com and ClearUpSkinCare.com.","Outlook includes OTCQB uplist and expansion of telemedicine platform Peaks."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-025770","json":"https://secwatch.observer/filing/0001493152-23-025770.json","markdown":"https://secwatch.observer/filing/0001493152-23-025770.md","text":"https://secwatch.observer/filing/0001493152-23-025770.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1538495/000149315223025770/0001493152-23-025770-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1538495/000149315223025770/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T23:01:08.741859+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}